ClinicalTrials.gov · NCT07475546 · Completed
Combination Gerotherapeutic Interventions for Healthspan Improvement
Registry record
NCT07475546 on ClinicalTrials.gov. The registry's last update to this record was 30 October 2026.
Verification record
5 checked · 0 company says · 0 reported · 0 not found · 0 not yet checked
- Title as registered Combination Gerotherapeutic Interventions for Healthspan Improvement Checked Source clinicaltrials.gov Brief title as registered. Checked
- Sponsor AgelessRx Checked Source clinicaltrials.gov Lead sponsor as registered. Checked
- Intervention Rapamycin; Naltrexone; Metformin; NAD+; GSH; Infinite Supplement; Placebo/control; B12 Checked Source clinicaltrials.gov Intervention names as registered. Checked
- Primary outcome as registered Change in cardiorespiratory fitness measured by maximal oxygen uptake (VO₂ max) | Change in cognitive performance measured by Creyos Cognitive Test | Change in systemic chronic inflammation measured by iAge index score | Change in lean body mass measured by dual-energy X-ray absorptiometry (DEXA) Checked Source clinicaltrials.gov Primary outcome measure(s) as registered. Checked
- Status Completed Checked Source clinicaltrials.gov Overall status as registered; registry last update 2026-10-30. Checked
Check history: NCT07475546 was last read on the registry on November 14, 2026. No earlier checks are recorded. How records are checked.
Corrections: none recorded for this trial. To ask for one, write to [email protected] with the registry number; every correction is checked against the registry record before the record changes.
As registered
- Sponsor: AgelessRx
- Phase: Phase 3
- Status: Completed
- Intervention: Rapamycin; Naltrexone; Metformin; NAD+; GSH; Infinite Supplement; Placebo/control; B12
- Primary outcome: Change in cardiorespiratory fitness measured by maximal oxygen uptake (VO₂ max) | Change in cognitive performance measured by Creyos Cognitive Test | Change in systemic chronic inflammation measured by iAge index score | Change in lean body mass measured by dual-energy X-ray absorptiometry (DEXA)
- Countries: United States
- Start: 23 July 2025
- Completion (actual): 9 April 2026
Results
No results were posted on the registry on the date checked. The Atlas does not summarize findings.
Related modality